Profil
John T.
Santini was the founder of Microchips Biotech, Inc., founded in 1999, where the title held was President & Chief Executive Officer.
Dr. Santini was the founder of ApoGen Biotechnologies, Inc., founded in 2014, where the title held was Director.
Current jobs include Operating Partner at Accelerator Services Corp and Chief Technology Officer at Vergent Bioscience, Inc. Former jobs include President & CEO at EpicentRx, Inc. from 2012 to 2013, President & Chief Executive Officer at On Demand Therapeutics, Inc., President at Exeter Venture Management Company LLC, and Chief Technology Officer at Irisense LLC from 2014 to 2015.
Education includes a doctorate from Massachusetts Institute of Technology conferred in 1999 and an undergraduate degree from the University of Michigan conferred in 1994.
Postes actifs de John Santini
| Sociétés | Poste | Début |
|---|---|---|
Vergent Bioscience, Inc.
Vergent Bioscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops cancer therapeutic products for surgery treatments | Directeur Technique/Scientifique/R&D | 09/06/2026 |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de John Santini
| Sociétés | Poste | Fin |
|---|---|---|
Irisense LLC | Directeur Technique/Scientifique/R&D | 02/01/2015 |
EpicentRx, Inc.
EpicentRx, Inc. BiotechnologyHealth Technology Develops novel therapies designed to target inflammatory diseases and supportive care conditions of unmet medical need | Directeur Général | 01/01/2013 |
ApoGen Biotechnologies, Inc.
ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company that focuses on the development of therapeutics targeting drivers of cancer genomic mutation | Fondateur | - |
On Demand Therapeutics, Inc.
On Demand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops implantable devices to enable on demand release of drugs to the back of the eye | Directeur Général | - |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Fondateur | - |
Formation de John Santini
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
EpicentRx, Inc.
EpicentRx, Inc. BiotechnologyHealth Technology Develops novel therapies designed to target inflammatory diseases and supportive care conditions of unmet medical need | Health Technology |
On Demand Therapeutics, Inc.
On Demand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops implantable devices to enable on demand release of drugs to the back of the eye | Health Technology |
Exeter Venture Management Company LLC
Exeter Venture Management Company LLC Investment ManagersFinance Flybridge Capital Partners invests in companies located in the United States. The firm focuses on AI sector companies. It provides financing for pre-seed, seed and early-stage and later stage capital requirements with an investment size of USD 0.25 - 10 million. It also acts as lead or co-lead investor. | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
ApoGen Biotechnologies, Inc.
ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company that focuses on the development of therapeutics targeting drivers of cancer genomic mutation | Health Technology |
Vergent Bioscience, Inc.
Vergent Bioscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops cancer therapeutic products for surgery treatments | Health Technology |
Irisense LLC |
















